Evidence map›Paper›PMID 37175873›Full record

ArticleInternational journal of molecular sciences2023

Roberto A Galeana-Ascencio, Liliana Mendieta, Daniel I Limon, Dino Gnecco, Joel L Terán, María L Orea, Alan Carrasco-Carballo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. A Graph Neural Network Framework with Equivariance and Heterogeneity for Drug Repositioning.Interdisciplinary sciences, computational life sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Current issues in molecular biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Roberto A Galeana-AscencioLaboratorio de Elucidación y Síntesis en Química Orgánica, ICUAP, BUAP, Puebla 72570, Mexico.
Liliana MendietaLaboratorio de Neuroquímica, FCQ, BUAP, Puebla 72570, Mexico.
Daniel I LimonLaboratorio de Neurofarmacología, FCQ, BUAP, Puebla 72570, Mexico.
Dino GneccoCentro de Química, ICUAP, BUAP, Puebla 72570, Mexico.
Joel L TeránCentro de Química, ICUAP, BUAP, Puebla 72570, Mexico.ORCID 0000-0002-4055-4353
María L OreaCentro de Química, ICUAP, BUAP, Puebla 72570, Mexico.ORCID 0000-0002-2535-1013
Alan Carrasco-CarballoLaboratorio de Elucidación y Síntesis en Química Orgánica, ICUAP, BUAP, Puebla 72570, Mexico.ORCID 0000-0003-1065-4211
Benemérita Universidad Autónoma de Puebla · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesHumansMolecular Docking SimulationPharmaceutical PreparationsAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesPharmaceutical PreparationsADMEAlzheimer’s diseasein silico drug repositionmolecular dockingβ-secretase 1

Identifiers

PMID37175873
PMCPMC10179340
OpenAlexW4368367206

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.